Status:
COMPLETED
Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage
Lead Sponsor:
Technical University of Munich
Conditions:
Aneurysmal Subarachnoid Haemorrhage
SAH
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The objective of this study is to determine whether a goal-directed therapy can reduce the incidence of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage.
Detailed Description
The aneurysmal subarachnoid haemorrhage (SAH) is a frequent and dangerous worldwide cause for stroke. A typical complication presents delayed cerebral ischemia as a consequence of cerebral vasospasms,...
Eligibility Criteria
Inclusion
- aneurysmal Subarachnoid Haemorrhage (SAH)
- Age ≥ 18 years
Exclusion
- traumatic SAH
- congestive heart failure
- severe diseases of aorta or aortic valve
- pregnancy
- calcium antagonist intolerance
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT01832389
Start Date
March 1 2013
End Date
December 1 2016
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München
München, Germany, 81675